Skip to main content

Table 1 Baseline demographics

From: Effect of Ramadan intermittent fasting on inflammatory markers, disease severity, depression, and quality of life in patients with inflammatory bowel diseases: A prospective cohort study

Number 80
Age* 32 (18–64)
Sex Males 41 (51), females 39 (49)
Smoking 4 (5), all CD
Disease type UC 60 (75)
CD 20 (25)
Time since diagnosis (years)* 3 (1–15)
Disease location  
UC  
Left-sided
Pancolitis
Ileocolonic
Isolated ileal
Proximal small bowel
31 (52)
29 (48)
14 (70)
5 (25)
1 (5)
Disease Phenotype (CD)  
Stenosing/penetrating
Inflammatory
12 (60)
8 (40)
Medications  
Biologics
Immunomodulators
Steroids
Oral Mesalamine
Number of current medications
0
1
2
3
4
40 (50)
57 (71)
15 (19)
51 (64)
3 (4)
16 (20)
38 (47)
20 (25)
3 (4)
Disease activity  
Partial Mayo score*
HBI*
1 (0–6)
5 (0–15)
  1. Number (percent)
  2. *Median (range)